|Articles|January 20, 2020
Case Study to Demonstrate Sensitivity in Immunogenicity Assay Should be Based on Result of Both Screening and Confirmatory Tier
Author(s)Syngene
Mahesh Kumar shares background, insights, and results of a study in which a relevant sensitivity and low positive control value in immunogenicity assays are identified.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
4
The Implications of the FDA’s New Finalized Guidance Documents
5